Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity
- PMID: 3282077
- DOI: 10.1093/jnci/80.5.310
Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity
Abstract
While the inherent radiosensitivity of tumor cells is likely to affect treatment outcome, the biochemical and physiologic state of the cell may have a major impact. Tumors are likely to be highly heterogeneous for these dynamic properties. Hypoxic cells are radioresistant, requiring two to three times the radiation dose to kill them compared to the same cells in a eu-oxic state. Hypoxia can be of two types: 1) chronic hypoxia, which is diffusion limited, and 2) acute hypoxia, which is perfusion limited. The mechanism of and approaches toward these are different and can serve as a model for other biochemical and physiologic processes that may affect treatment outcome.
Similar articles
-
Oxygen, hydrogen donors and radiation response.Adv Exp Med Biol. 1982;157:147-75. doi: 10.1007/978-1-4684-4388-2_14. Adv Exp Med Biol. 1982. PMID: 7158519 No abstract available.
-
The search for new hypoxic cell radiosensitizers.J Natl Med Assoc. 1980 Aug;72(8):765-9. J Natl Med Assoc. 1980. PMID: 7401185 Free PMC article.
-
A voxel-based multiscale model to simulate the radiation response of hypoxic tumors.Med Phys. 2015 Jan;42(1):90-102. doi: 10.1118/1.4903298. Med Phys. 2015. PMID: 25563250
-
Eighth annual Juan del Regato lecture. Chemical modifiers of radiosensitivity--theory and reality: a review.Int J Radiat Oncol Biol Phys. 1985 Apr;11(4):665-74. doi: 10.1016/0360-3016(85)90296-2. Int J Radiat Oncol Biol Phys. 1985. PMID: 3884559 Review.
-
Determinants of radiosensitivity.Semin Oncol. 1985 Sep;12(3):332-49. Semin Oncol. 1985. PMID: 3901268 Review. No abstract available.
Cited by
-
Gene Therapy of Chronic Limb-Threatening Ischemia: Vascular Medical Perspectives.J Clin Med. 2022 Feb 26;11(5):1282. doi: 10.3390/jcm11051282. J Clin Med. 2022. PMID: 35268373 Free PMC article. Review.
-
Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1403-10. doi: 10.1016/j.ijrobp.2009.07.009. Epub 2009 Nov 10. Int J Radiat Oncol Biol Phys. 2010. PMID: 19906496 Free PMC article.
-
Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069).Cancer Chemother Pharmacol. 1991;29(1):37-47. doi: 10.1007/BF00686334. Cancer Chemother Pharmacol. 1991. PMID: 1742848
-
Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.Br J Cancer. 1991 Jan;63(1):109-13. doi: 10.1038/bjc.1991.22. Br J Cancer. 1991. PMID: 1846549 Free PMC article.
-
Antitumor effect of a Pt-loaded nanocomposite based on graphene quantum dots combats hypoxia-induced chemoresistance of oral squamous cell carcinoma.Int J Nanomedicine. 2018 Mar 13;13:1505-1524. doi: 10.2147/IJN.S156984. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29559779 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources